Reaction

Benign Breast Neoplasm reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,013 reports · 8 co-occurring drugs

As of the last recalculation, Benign Breast Neoplasm appears in 1,013 FAERS reports alongside 8 co-occurring drug terms. The strongest observed disproportionality signal is CONJUGATED ESTROGENS (PRR 23.6).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Conjugated Estrogens6323.623.6
Estrogens, Conjugated6423.623.6
Raloxifene Hydrochloride1115.615.7
Conjugated Estrogens And Medroxyprogesterone Acetate1715.015.0
Etonogestrel And Ethinyl Estradiol1110.310.3
Medroxyprogesterone Acetate2410.110.1
Etonogestrel73.03.0
Levonorgestrel232.42.4

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.